Technology/Therapeutic Development Award – HT942524SMBRP
- up to USD$2.2M over 3 years
- pre-proposals due 3 June 2024
- supports the translation of promising pre-clinical findings into products for clinical applications
- product oriented (eg device, drug, clinical guidelines). Product may be a tangible item (eg drugs or biologics) or a device, or a knowledge-based product
- proof-of-concept demonstrating utility or prototype/preliminary version required
- preliminary data required
- clinical trials not allowed
- must address at least one focus area
- Document: Funding Opportunity: HT942524SMBRP-TTDA-BAA_GG
Patient-Centered Research Program – HT942524MBRPPCRA
- up to USD$2.2M over 3 years
- pre-proposals due 3 June 2024
- bridges gap between research, practice and policy by building a knowledge base on how interventions and clinical practices/guidelines and policies can be deployed to targeted populations at the appropriate time at the point of need
- funding must support clinical research or clinical trials
- cannot be used for pre-clinical or animal research
- preliminary data required
- must address at least one focus area
- Document: Funding Opportunity: HT942524MBRPPCRA_GG_v2
Focus Areas
- Atypical Burns – Development and/or validation of methods to assess, treat, and/or prevent the progression of burns resulting from cold exposure, radiation, directed energy, chemical, or high voltage/combat-related electrical injuries.
- Burn Knowledge Products – Research to innovate best practices in the acute burn care continuum.
- Burn Injury-Related Complications – Development and/or validation of methods to prevent, assess and/or treat burn injury-related complications including over/under fluid resuscitation to include limited or low volume resuscitation; acute respiratory distress syndrome; sepsis; inhalation injuries; peripheral neuropathy; chronification of pain (prevention only).
